President Trump’s seemingly top priority is to keep the promises he made on the campaign trail and remake the federal government.
But judging from his first set of budget proposals to Congress, doing so is likely to come at the expense of those in need.
Advocates for lower-income Americans see the president’s proposed spending cuts in his “skinny” budget as an assault.
“This isn’t a budget that will make America great again. It’s a budget that will increase hardship and poverty,” said Robert Greenstein, president of the liberal Center on Budget and Policy Priorities.
When asked at a press briefing if the president’s spending blueprint is hard-hearted because it would cut programs that help low-income children and seniors, White House Budget Director Mick Mulvaney said he felt it was “as compassionate as you can get.”
“You’re only focusing on half of the equation, right? You’re focusing on recipients of the money. We’re trying to focus on both the recipients of the money and the folks who give us the money in the first place. [I]t’s fairly compassionate to go to them and say, look, ‘We’re not going to ask you for your hard-earned money anymore … unless we can guarantee to you that that money is actually being used in a proper function.”
Hot Stocks To Invest In Right Now: Lumber Liquidators Holdings, Inc(LL)
- [By Daniel Miller]
If you remember about a year ago, the Centers for Disease Control and Prevention let the world know that consumers who had purchased the China-produced flooring from Lumber Liquidators Holdings (NYSE:LL) were roughly three times more likely to fall ill with cancer. That rate was much higher than earlier calculations following the 2015 broadcast by CBS’ 60 Minutes.The stock shed much of its value since the 2015 airing, but rebounded 17% on Tuesday after it reported a narrower-than-expected loss during the fourth quarter, offering investors a slight amount of hope going forward.
- [By Peter Graham]
Small cap hardwood flooring stockLumber Liquidators Holdings Inc (NYSE: LL) reportedQ2 2017 earnings before the market opened this morning with better than expected earnings sending shares soaring as the Company went into earnings with short interest of 24.68% according to Highshortinterest.com. Net sales increased10.7% to $263.5 million as net sales in comparable stores increased 8.8% driven by a 5.3% increase in the number of customers invoiced and a 3.5% increase in the average sale. Merchandise sales in comparable stores grew 6.1% in the quarter whilenet sales in non-comparable stores increased $4.4 million. The Company did not open any stores during the second quarter of 2017 with the total store count remaining at 385 as of June 30, 2017. Net income was $4.5 million versusa net loss of $12.2 million for the first profit in the wake of a 2015 “60 Minutes” report that claimed the Companys laminate flooring contained high levels of cancer-causing formaldehyde.
- [By Peter Graham]
The Q4 2016 earnings report for small cap hardwood flooring stockLumber Liquidators Holdings Inc (NYSE: LL) is scheduled for before the market opens onTuesday (February 21th). Lumber Liquidators Holdingshad been ahighflying stock until the middle of 2013 when shares were hit be allegations that the companys flooring products contained illegal levels of formaldehyde. Shares then took another hit on reports that the Department of Homeland Security andthe USFish and Wildlife Servicehad executed a sealed court-issuedsearch/raid on theheadquarters for possible sourcing violations.Lumber Liquidators Holdingslater won a favorable ruling in a California lawsuit filed under the state’s Proposition 65 covering cancer-causing chemicals and agreed to pay $2.5 million (without admitting wrongdoing) to settle a civil matter with the California Air Resources Board.
Hot Stocks To Invest In Right Now: PetroChina Company Limited(PTR)
- [By Money Morning News Team]
PetroChina Co. Ltd. (NYSE ADR: PTR) is China’s largest oil company with a market cap of $216.52 billion. PTR is partially owned by the Chinese government.
Hot Stocks To Invest In Right Now: Lithium X Energy Corp. (LIXXF)
- [By SEEKINGALPHA.COM]
The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].
- [By Tom Bishop]
Lithium X Energy NPV (LIXXF) owns 50% of the Sal de los Angeles lithium brine project in the prolific “Lithium Triangle” in mining friendly Salta province, Argentina.
Hot Stocks To Invest In Right Now: (SMPQY)
- [By SEEKINGALPHA.COM]
The majority owner is Sun Pharma (OTC:SMPQY) (the largest drug business in India). There have been a number of articles that have outlined Sun Pharma and its quest for Taro, but it makes a lot of sense for Sun to want to own all – and not just the majority – of Taro. One big reason is that owning all of Taro means that any investments that Sun makes with Taros $1.2 billion cash hoard will not be diluted by the presence of minority shareholders. Another reason that Sun likely wants Taro is simply because it is very cheap right now. Sun is run by its founder and majority shareholder, Dilip Shanghvi, who is sort of a pharmaceutical value investor who has opportunistically made acquisitions and investments over time, building his firm starting with a loan of $200 in the early 1980s to the multi-billion business it is today.
- [By SEEKINGALPHA.COM]
We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ